 Tomoko Matsuo
Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipoproteins, LDL | 4 | 2006 | 119 | 0.360 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 2006 | 161 | 0.270 |
Why?
| | Prostaglandin D2 | 1 | 2004 | 21 | 0.210 |
Why?
| | Surgical Staplers | 2 | 2013 | 5 | 0.190 |
Why?
| | Anastomosis, Surgical | 2 | 2013 | 162 | 0.180 |
Why?
| | Candidiasis, Cutaneous | 1 | 2020 | 2 | 0.160 |
Why?
| | Diaper Rash | 1 | 2020 | 5 | 0.160 |
Why?
| | Candidiasis, Vulvovaginal | 1 | 2020 | 5 | 0.160 |
Why?
| | Soaps | 1 | 2020 | 10 | 0.160 |
Why?
| | NF-kappa B | 1 | 2004 | 666 | 0.160 |
Why?
| | Tachykinins | 1 | 2019 | 9 | 0.160 |
Why?
| | Skin Care | 1 | 2020 | 22 | 0.160 |
Why?
| | Pruritus | 1 | 2019 | 59 | 0.150 |
Why?
| | Macrophages | 2 | 2004 | 1507 | 0.150 |
Why?
| | Antifungal Agents | 1 | 2020 | 151 | 0.140 |
Why?
| | Ergonomics | 2 | 2013 | 29 | 0.120 |
Why?
| | Peptide Fragments | 1 | 2019 | 693 | 0.120 |
Why?
| | Macrophages, Peritoneal | 2 | 2006 | 89 | 0.110 |
Why?
| | Physicians | 2 | 2013 | 955 | 0.100 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2004 | 264 | 0.100 |
Why?
| | Surgical Stapling | 1 | 2013 | 15 | 0.100 |
Why?
| | Cell Proliferation | 3 | 2006 | 2507 | 0.100 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2013 | 46 | 0.100 |
Why?
| | Pyrazines | 1 | 2013 | 94 | 0.090 |
Why?
| | Hand Strength | 1 | 2013 | 144 | 0.090 |
Why?
| | Consumer Behavior | 1 | 2012 | 69 | 0.090 |
Why?
| | Triazoles | 1 | 2013 | 187 | 0.090 |
Why?
| | Mice, Inbred C3H | 3 | 2006 | 254 | 0.080 |
Why?
| | Gastroenterology | 1 | 2012 | 191 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 135 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 2 | 2006 | 171 | 0.060 |
Why?
| | Chromans | 1 | 2006 | 24 | 0.060 |
Why?
| | Thiazolidinediones | 1 | 2006 | 139 | 0.060 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2004 | 76 | 0.050 |
Why?
| | Thymidine | 1 | 2004 | 60 | 0.050 |
Why?
| | Cyclopentanes | 1 | 2004 | 17 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 1193 | 0.050 |
Why?
| | Glomerular Mesangium | 1 | 2003 | 21 | 0.050 |
Why?
| | Luciferases | 1 | 2004 | 153 | 0.050 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2004 | 88 | 0.050 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 75 | 0.050 |
Why?
| | Deoxyguanosine | 1 | 2003 | 25 | 0.050 |
Why?
| | Blood Glucose | 1 | 2013 | 2341 | 0.050 |
Why?
| | Isoenzymes | 1 | 2003 | 294 | 0.050 |
Why?
| | Japan | 2 | 2013 | 149 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2004 | 1246 | 0.050 |
Why?
| | Cell Division | 1 | 2004 | 756 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2004 | 372 | 0.040 |
Why?
| | Transfection | 1 | 2004 | 926 | 0.040 |
Why?
| | Physicians, Women | 2 | 2013 | 89 | 0.040 |
Why?
| | Hypoglycemic Agents | 2 | 2013 | 1399 | 0.040 |
Why?
| | Diabetic Angiopathies | 1 | 2003 | 264 | 0.040 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2004 | 443 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2003 | 611 | 0.040 |
Why?
| | Base Sequence | 1 | 2004 | 2170 | 0.040 |
Why?
| | Diapers, Adult | 1 | 2020 | 1 | 0.040 |
Why?
| | Miconazole | 1 | 2020 | 5 | 0.040 |
Why?
| | Histamine | 1 | 2019 | 52 | 0.040 |
Why?
| | Candida | 1 | 2020 | 45 | 0.040 |
Why?
| | Chloroquine | 1 | 2019 | 54 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2019 | 94 | 0.040 |
Why?
| | Injections, Spinal | 1 | 2019 | 119 | 0.040 |
Why?
| | Urinary Incontinence | 1 | 2020 | 65 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 2028 | 0.040 |
Why?
| | Male | 9 | 2020 | 72843 | 0.040 |
Why?
| | Gene Expression | 1 | 2003 | 1476 | 0.030 |
Why?
| | Cell Line | 1 | 2004 | 2823 | 0.030 |
Why?
| | DNA | 1 | 2004 | 1435 | 0.030 |
Why?
| | Mitochondria | 1 | 2003 | 992 | 0.030 |
Why?
| | Behavior, Animal | 1 | 2019 | 519 | 0.030 |
Why?
| | Mice | 4 | 2006 | 18329 | 0.030 |
Why?
| | Animals | 5 | 2019 | 38030 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2013 | 2588 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2524 | 0.030 |
Why?
| | Sitagliptin Phosphate | 1 | 2013 | 31 | 0.020 |
Why?
| | Deoxyglucose | 1 | 2013 | 51 | 0.020 |
Why?
| | Gloves, Surgical | 1 | 2012 | 4 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2930 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2012 | 536 | 0.020 |
Why?
| | Humans | 8 | 2020 | 145475 | 0.020 |
Why?
| | Aged | 3 | 2020 | 26153 | 0.020 |
Why?
| | Middle Aged | 4 | 2013 | 36215 | 0.020 |
Why?
| | Hypoglycemia | 1 | 2013 | 479 | 0.020 |
Why?
| | Female | 5 | 2020 | 78845 | 0.020 |
Why?
| | Insulin | 2 | 2013 | 2512 | 0.020 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2013 | 701 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 8057 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8333 | 0.020 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2004 | 15 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2020 | 11772 | 0.010 |
Why?
| | Simvastatin | 1 | 2004 | 59 | 0.010 |
Why?
| | Body Mass Index | 1 | 2013 | 2445 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2004 | 83 | 0.010 |
Why?
| | Lipid Peroxidation | 1 | 2004 | 167 | 0.010 |
Why?
| | Thenoyltrifluoroacetone | 1 | 2003 | 1 | 0.010 |
Why?
| | Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2003 | 4 | 0.010 |
Why?
| | Stress, Psychological | 1 | 2012 | 1146 | 0.010 |
Why?
| | Uncoupling Protein 1 | 1 | 2003 | 17 | 0.010 |
Why?
| | Ionophores | 1 | 2003 | 24 | 0.010 |
Why?
| | Cyclooxygenase 1 | 1 | 2003 | 27 | 0.010 |
Why?
| | Tunica Media | 1 | 2003 | 37 | 0.010 |
Why?
| | Chelating Agents | 1 | 2003 | 76 | 0.010 |
Why?
| | Carotid Artery, Common | 1 | 2003 | 31 | 0.010 |
Why?
| | Tunica Intima | 1 | 2003 | 78 | 0.010 |
Why?
| | Ion Channels | 1 | 2003 | 129 | 0.010 |
Why?
| | Cyclooxygenase 2 | 1 | 2003 | 166 | 0.010 |
Why?
| | Diabetic Neuropathies | 1 | 2003 | 100 | 0.010 |
Why?
| | Albuminuria | 1 | 2003 | 189 | 0.010 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2003 | 199 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2004 | 372 | 0.010 |
Why?
| | Superoxide Dismutase | 1 | 2003 | 308 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2003 | 263 | 0.010 |
Why?
| | Creatinine | 1 | 2003 | 515 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2003 | 782 | 0.010 |
Why?
| | Signal Transduction | 2 | 2004 | 5216 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2004 | 1067 | 0.010 |
Why?
| | Diabetic Retinopathy | 1 | 2003 | 209 | 0.010 |
Why?
| | Pyridines | 1 | 2004 | 609 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2012 | 6066 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2003 | 728 | 0.010 |
Why?
| | Adult | 2 | 2013 | 40777 | 0.010 |
Why?
| | Glucose | 1 | 2003 | 1048 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2003 | 1164 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2003 | 4148 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2803 | 0.010 |
Why?
| | Inflammation | 1 | 2004 | 2878 | 0.010 |
Why?
| | Biomarkers | 1 | 2003 | 4295 | 0.010 |
Why?
| | Risk Factors | 1 | 2003 | 10885 | 0.000 |
Why?
|
|
Matsuo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|